MarketResearchReports.Biz
announces addition of new report"
Premature Ejaculation - Pipeline Review, H1 2016 "to
its database.
Global
Markets Directs, Premature
Ejaculation - Pipeline Review, H1 2016,
provides an overview of the Premature Ejaculation pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Premature Ejaculation, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Premature Ejaculation and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report @
Scope
- The report provides a
snapshot of the global therapeutic landscape of Premature Ejaculation
- The report reviews pipeline
therapeutics for Premature Ejaculation by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved Premature Ejaculation therapeutics and enlists all
their major and minor projects
- The report assesses Premature
Ejaculation therapeutics based on drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news related to pipeline therapeutics for Premature Ejaculation
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Premature Ejaculation
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding Premature Ejaculation pipeline
depth and focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic
portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Table
of Content :
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Premature
Ejaculation Overview 6
Therapeutics
Development 7
Pipeline
Products for Premature Ejaculation - Overview 7
Premature
Ejaculation - Therapeutics under Development by Companies 8
Premature
Ejaculation - Pipeline Products Glance 9
Late
Stage Products 9
Clinical
Stage Products 10
Early
Stage Products 11
Premature
Ejaculation - Products under Development by Companies 12
Premature
Ejaculation - Companies Involved in Therapeutics Development 13
Allergan
Plc 13
Aytu
BioScience, Inc. 14
Ixchelsis
Limited 15
NeuroHealing
Pharmaceuticals Inc. 16
Plethora
Solutions Holdings Plc 17
SK
Chemicals Co., Ltd. 18
Premature
Ejaculation - Therapeutics Assessment 19
Assessment
by Monotherapy Products 19
Assessment
by Combination Products 20
Assessment
by Target 21
Assessment
by Mechanism of Action 23
Assessment
by Route of Administration 25
Assessment
by Molecule Type 27
Drug
Profiles 29
(lidocaine
+ prilocaine) - Drug Profile 29
Product
Description 29
Mechanism
of Action 29
R&D
Progress 29
(PDE-5
Inhibitor + tramadol hydrochloride) - Drug Profile 31
Product
Description 31
Mechanism
of Action 31
R&D
Progress 31
IX-01
- Drug Profile 32
Product
Description 32
Mechanism
of Action 32
R&D
Progress 32
modafinil
- Drug Profile 33
Product
Description 33
Mechanism
of Action 33
R&D
Progress 33
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment